PendreaBio Competitors and Similar CompaniesClear all
PendreaBio's competitors and similar companies include Co-D Therapeutics, Cristal Therapeutics, Dare Bioscience and NexImmune.
 PendreaBio PendreaBio (also known as Keystone Nano) is a company that provides nanoscale solutions for the treatment of cancer. |  Co-D Therapeutics Co-D Therapeutics is a drug development company dedicated to developing combination nano-medicines to treat cancer. |  Cristal Therapeutics Cristal Therapeutics is a clinical-stage pharmaceutical company developing targeted nanomedicines with therapeutic profiles for the treatment of cancer and other diseases. |  Dare Bioscience Dare Bioscience (formerly Cerulean Pharma) develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases. |  NexImmune NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform. | |
Founding Date | Founding Date 2005 | Founding Date 2012 | Founding Date 2011 | Founding Date 2006 | Founding Date 2011 |
Type | Type Private | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations State College, US HQ | Locations Madison, US HQ | Locations Maastricht, NL HQ | Locations San Diego, US HQ | Locations Gaithersburg, US HQ |
Employees | Employees 4 | Employees 4 | Employees 4 | Employees 980% increase | Employees 5032% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 33.8 m | Valuation ($) 372.4 k |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income N/A | Net income ($13.4m) (FY, 2025) | Net income ($32.3m) (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 26.8m | Total funding raised $ 115.7m | Total funding raised $ 33.8m |
For sources of this data, please see the company profile
View Company Profiles
Co-D Therapeutics
HQ
Madison, US
Employees
4
Co-D Therapeutics is a drug development company dedicated to developing combination nano-medicines to treat cancer.
View companyCristal Therapeutics
HQ
Maastricht, NL
Employees
4
Cristal Therapeutics is a clinical-stage pharmaceutical company developing targeted nanomedicines with therapeutic profiles for the treatment of cancer and other diseases.
View companyDare Bioscience
HQ
San Diego, US
Employees
9
Dare Bioscience (formerly Cerulean Pharma) develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
View companyNexImmune
HQ
Gaithersburg, US
Employees
50↓ 32% decrease
NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform.
View company